×
We're aware of a cyber security incident affecting the electronic prescriptions provider MediSecure. The eRX Script Exchange (eRX) and the National Prescription Delivery Service (NPDS) continue to operate as usual and have not been impacted. Find out more and read our statement here.

Submission on the Regulatory options to allow references to the TGA in therapeutic goods advertising consultation


Last updated 21 November 2023

Date: 5 December 2022

The RACGP has provided a response to the Department of Health and Aged Care on the Regulatory options to allow references to the TGA in therapeutic goods advertising consultation. The RACGP’s response supports retaining the option prohibiting referencing the TGA or any government approval process in therapeutic goods advertising. We highlight that adding “TGA approved”, “TGA registered” or the equivalent in an advertisement implies endorsement and is therefore misleading.

Read the submission

Submission on the Regulatory options to allow references to the TGA in therapeutic goods advertising consultation (PDF)

Advertising

Advertising